Report Code : CVMI29071 | Published Date : July 29, 2025

Market Overview

Syndromic multiplex diagnostics refer to rapid molecular testing panels that detect multiple pathogens responsible for overlapping symptoms in a single test. These panels cover respiratory infections, gastrointestinal diseases, bloodstream infections, and sexually transmitted infections (STIs), enabling clinicians to make faster and more accurate treatment decisions. The market has quickly expanded due to increased demand for point-of-care testing, the necessity to combat antimicrobial resistance, and lessons learned from the COVID-19 pandemic regarding rapid pathogen identification and isolation protocols.

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

1.82

Pre-pandemic usage driven by respiratory and GI testing

2024

4.78

Boosted by COVID-19 demand and STI panel expansion

2031

9.65

Seven-year CAGR 10.7% (2024–2031)

Market growth is driven by decentralized testing adoption, expanded FDA approvals, and rising hospital-acquired infection (HAI) prevention programs.

Primary Market Drivers

• Demand for rapid, multi-pathogen detection across respiratory, GI, and CNS conditions
• Increase in antimicrobial stewardship programs requiring accurate diagnostics
• Expansion of CLIA-waived molecular testing to urgent care and physician offices
• Integration with electronic health records for immediate reporting and surveillance
• Pandemic-driven investments in decentralized and syndromic diagnostics infrastructure

Market Challenges

• High per-test cost compared to single-pathogen molecular or antigen tests
• Reimbursement and payer approval issues for comprehensive panels
• Workflow integration challenges in low-resource and small clinical settings
• False positives or detection of colonizing pathogens leading to overtreatment risks
• Regulatory complexity for panels with evolving target lists

Competitive Landscape

Company / Organization

2024 Share

Core Strengths

Recent Moves

BioFire Diagnostics (bioMérieux)

35 %

Broadest panel offerings and global install base

Launched GI panel lite for decentralized use (Q2 2024)

Cepheid (Danaher)

22 %

CLIA-waived respiratory and STI multiplex assays

Expanded GeneXpert Edge platform for mobile clinics (Q1 2025)

QIAGEN

11 %

Syndromic workflows integrated with automation

Introduced multiplex pneumonia + resistance marker panel (Q3 2024)

Luminex (Diasorin)

9 %

xTAG and Aries platform with customizable panels

Approved CNS panel expansion in Europe (Q4 2024)

Others (GenMark, Mobidiag, Seegene)

23 %

Rapid innovations in regional test menus

Entered LATAM and MEA markets through local licensing

Detailed Market Segmentation

By Syndrome Type
• Respiratory Infection Panels – 36 %
• Gastrointestinal Infection Panels – XX %
• Bloodstream / Sepsis Panels – XX %
• CNS / Meningitis & Encephalitis Panels – XX %
• STI & Urogenital Panels – XX %

By End User
• Hospitals & Emergency Rooms – 45 %
• Reference Laboratories – XX %
• Physician Offices & Urgent Care – XX %
• Mobile & Field Testing Units – XX %

By Platform
• PCR-Based Systems – 68 %
• Microarray-Based Platforms – XX %
• Isothermal Nucleic Acid Amplification – XX %
• Others (CRISPR, Nanopore) – XX %

Regional Analysis

• North America (41%) – High syndromic panel usage and payer support; expanded mobile diagnostics
• Europe (XX%) – Strong adoption in national health systems and antimicrobial stewardship initiatives
• Asia-Pacific (XX%) – Fastest-growing region; increasing decentralization in China and India
• Latin America & MEA (XX%) – Panel customization and NGO-supported deployments in infection hotspots

Technology and Innovation

• AI-driven result interpretation for resistance marker patterns
• Cartridge miniaturization and panel modularity for flexible pricing
• Direct-from-sample workflows reducing pre-analytical errors
• Cloud-based surveillance dashboards integrated with test platforms
• Multiplex CRISPR diagnostics for emerging pathogen detection

Regulatory Environment

• FDA moves from EUA to full clearance for respiratory and GI panels after the pandemic
• CE-IVDR compliance enhances transparency and performance benchmarking
• WHO endorses syndromic platforms for HAI containment and AMR control
• CMS and private payers expand reimbursement codes for broad respiratory and sepsis panels

Recent Developments (Q4 2023 – Q2 2025)

• BioFire launches GI Lite panel with targeted pricing (Q2 2024)
• Cepheid introduces mobile-compatible STI panel on Edge platform (Q1 2025)
• QIAGEN receives EU approval for multiplex pneumonia and resistance markers (Q3 2024)
• Diasorin-Luminex expands CNS panel for tropical pathogens (Q4 2024)
• Seegene integrates AI analytics for resistance gene tracking (Q1 2025)

Strategic Outlook

• Diagnostic OEMs should prioritize modular pricing and rural deployment models
• Hospitals must integrate syndromic panels with antimicrobial stewardship dashboards
• Governments and global health partners can co-fund decentralized panel rollouts for outbreak readiness
• Investment in panels detecting resistance genes will offer long-term infection control returns

Methodology

Clearview Market Insights gathered syndromic test volume data from hospitals, interviewed 45 infectious disease specialists and lab managers, and tracked platform deployment across 24 countries. Forecasts include payer policies, platform capacity expansion, and infectious disease prevalence trends.

About Clearview Market Insights

Clearview Market Insights delivers infectious disease diagnostic intelligence to device manufacturers, hospitals, global health agencies, and clinical lab networks worldwide.





Reasons To Buy

Image



Scope

Image

BioFire Diagnostics (bioMérieux)

Cepheid (Danaher)

QIAGEN

Luminex (Diasorin)

GenMark

Mobidiag

Seegene

Abbott Laboratories

Thermo Fisher Scientific Inc

F. Hoffmann-La Roche Ltd

Global Syndromic Multiplex Diagnostics Market Report


  1. 1. Global Syndromic Multiplex Diagnostics Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Syndromic Multiplex Diagnostics Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Global Syndromic Multiplex Diagnostics Market Research Report - Preface
    1. 2.1 Global Syndromic Multiplex Diagnostics Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Syndrome Type
      2. 2.1.2 By End User
      3. 2.1.3 By Platform
      4. 2.1.4 By Region
  3. 3. Global Syndromic Multiplex Diagnostics Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Syndrome Type, By End User, By Platform, By Country
    3. 3.3. Opportunities – By Syndrome Type, By End User, By Platform, By Country
    4. 3.4. Trends – By Syndrome Type, By End User, By Platform, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Syndromic Multiplex Diagnostics Market Research Report – DROTs Impact Analysis
    1. 4. Global Syndromic Multiplex Diagnostics Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Global Syndromic Multiplex Diagnostics Market, By Syndrome Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Respiratory Infection Panels
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Gastrointestinal Infection Panels
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Bloodstream / Sepsis Panels
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 CNS / Meningitis & Encephalitis Panels
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    21. 5.5 STI & Urogenital Panels
    22. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    23. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    24. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    25. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Syndromic Multiplex Diagnostics Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals & Emergency Rooms
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Reference Laboratories
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Physician Offices & Urgent Care
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 6.4 Mobile & Field Testing Units
    17. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Syndromic Multiplex Diagnostics Market, By Platform, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 PCR-Based Systems
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 Microarray-Based Platforms
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Isothermal Nucleic Acid Amplification
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 7.4 Others (CRISPR, Nanopore)
    17. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Global Syndromic Multiplex Diagnostics Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East and Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Global Syndromic Multiplex Diagnostics Market - Opportunity Analysis Index, By Syndrome Type, By End User, By Platform, and Region, 2024 - 2031
  1. 9. North America Global Syndromic Multiplex Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Syndrome Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Respiratory Infection Panels
      2. 9.1.2 Gastrointestinal Infection Panels
      3. 9.1.3 Bloodstream / Sepsis Panels
      4. 9.1.4 CNS / Meningitis & Encephalitis Panels
      5. 9.1.5 STI & Urogenital Panels
      9.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Hospitals & Emergency Rooms
      2. 9.2.2 Reference Laboratories
      3. 9.2.3 Physician Offices & Urgent Care
      4. 9.2.4 Mobile & Field Testing Units
      9.3 By Platform Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 PCR-Based Systems
      2. 9.3.2 Microarray-Based Platforms
      3. 9.3.3 Isothermal Nucleic Acid Amplification
      4. 9.3.4 Others (CRISPR, Nanopore)
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 U.S
      2. 9.4.2 Canada
    2. 9.5 North America Global Syndromic Multiplex Diagnostics Market – Opportunity Analysis Index, By Syndrome Type, By End User, By Platform, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 North America Global Syndromic Multiplex Diagnostics Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (U.S)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Syndromic Multiplex Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Syndrome Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Respiratory Infection Panels
      2. 10.1.2 Gastrointestinal Infection Panels
      3. 10.1.3 Bloodstream / Sepsis Panels
      4. 10.1.4 CNS / Meningitis & Encephalitis Panels
      5. 10.1.5 STI & Urogenital Panels
      10.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hospitals & Emergency Rooms
      2. 10.2.2 Reference Laboratories
      3. 10.2.3 Physician Offices & Urgent Care
      4. 10.2.4 Mobile & Field Testing Units
      10.3 By Platform Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 PCR-Based Systems
      2. 10.3.2 Microarray-Based Platforms
      3. 10.3.3 Isothermal Nucleic Acid Amplification
      4. 10.3.4 Others (CRISPR, Nanopore)
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 UK
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Poland and Rest of Europe
    2. 10.5 Europe Global Syndromic Multiplex Diagnostics Market – Opportunity Analysis Index, By Syndrome Type, By End User, By Platform, and Country, 2024 - 2031
    3. 10.6 Regional Trends Analysis
    4. 10.7 Europe Global Syndromic Multiplex Diagnostics Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (UK)
      3. 10.7.3 Company 3 (UK)
    11. Asia-Pacific Global Syndromic Multiplex Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Syndrome Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Respiratory Infection Panels
      2. 11.1.2 Gastrointestinal Infection Panels
      3. 11.1.3 Bloodstream / Sepsis Panels
      4. 11.1.4 CNS / Meningitis & Encephalitis Panels
      5. 11.1.5 STI & Urogenital Panels
      11.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hospitals & Emergency Rooms
      2. 11.2.2 Reference Laboratories
      3. 11.2.3 Physician Offices & Urgent Care
      4. 11.2.4 Mobile & Field Testing Units
      11.3 By Platform Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 PCR-Based Systems
      2. 11.3.2 Microarray-Based Platforms
      3. 11.3.3 Isothermal Nucleic Acid Amplification
      4. 11.3.4 Others (CRISPR, Nanopore)
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Japan
      2. 11.4.2 China
      3. 11.4.3 India
      4. 11.4.4 ASEAN
      5. 11.4.5 Australia & New Zealand
      6. 11.4.6 Rest of Asia-Pacific
    2. 11.5 Asia-Pacific Global Syndromic Multiplex Diagnostics Market – Opportunity Analysis Index, By Syndrome Type, By End User, By Platform, and Country, 2024 - 2031
    3. 11.6 Regional Trends Analysis
    4. 11.7 Asia-Pacific Global Syndromic Multiplex Diagnostics Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (Japan)
      2. 11.7.2 Company 2 (China)
      3. 11.7.3 Company 3 (China)
    12. Latin America Global Syndromic Multiplex Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Syndrome Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Respiratory Infection Panels
      2. 12.1.2 Gastrointestinal Infection Panels
      3. 12.1.3 Bloodstream / Sepsis Panels
      4. 12.1.4 CNS / Meningitis & Encephalitis Panels
      5. 12.1.5 STI & Urogenital Panels
      12.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hospitals & Emergency Rooms
      2. 12.2.2 Reference Laboratories
      3. 12.2.3 Physician Offices & Urgent Care
      4. 12.2.4 Mobile & Field Testing Units
      12.3 By Platform Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 PCR-Based Systems
      2. 12.3.2 Microarray-Based Platforms
      3. 12.3.3 Isothermal Nucleic Acid Amplification
      4. 12.3.4 Others (CRISPR, Nanopore)
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Rest of Latin America
    2. 12.5 Latin America Global Syndromic Multiplex Diagnostics Market – Opportunity Analysis Index, By Syndrome Type, By End User, By Platform, and Country, 2024 - 2031
    3. 12.6 Regional Trends Analysis
    4. 12.7 Latin America Global Syndromic Multiplex Diagnostics Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East and Africa Global Syndromic Multiplex Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Syndrome Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Respiratory Infection Panels
      2. 13.1.2 Gastrointestinal Infection Panels
      3. 13.1.3 Bloodstream / Sepsis Panels
      4. 13.1.4 CNS / Meningitis & Encephalitis Panels
      5. 13.1.5 STI & Urogenital Panels
      13.2 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Hospitals & Emergency Rooms
      2. 13.2.2 Reference Laboratories
      3. 13.2.3 Physician Offices & Urgent Care
      4. 13.2.4 Mobile & Field Testing Units
      13.3 By Platform Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 PCR-Based Systems
      2. 13.3.2 Microarray-Based Platforms
      3. 13.3.3 Isothermal Nucleic Acid Amplification
      4. 13.3.4 Others (CRISPR, Nanopore)
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Gulf Cooperation Council (GCC) Countries
      2. 13.4.2 Israel
      3. 13.4.3 South Africa
      4. 13.4.4 Rest of MEA
    2. 13.5 Middle East and Africa Global Syndromic Multiplex Diagnostics Market – Opportunity Analysis Index, By Syndrome Type, By End User, By Platform, and Country, 2024 - 2031
    3. 13.6 Regional Trends Analysis
    4. 13.7 Middle East and Africa Global Syndromic Multiplex Diagnostics Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Gulf Cooperation Council (GCC) Countries)
      2. 13.7.2 Company 2 (Israel)
      3. 13.7.3 Company 3 (Israel)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 BioFire Diagnostics (bioMérieux)
      2. 14.2.2 Cepheid (Danaher)
      3. 14.2.3 QIAGEN
      4. 14.2.4 Luminex (Diasorin)
      5. 14.2.5 GenMark
      6. 14.2.6 Mobidiag
      7. 14.2.7 Seegene
      8. 14.2.8 Abbott Laboratories
      9. 14.2.9 Thermo Fisher Scientific Inc
      10. 14.2.10 F. Hoffmann-La Roche Ltd
  1. 15. Data Collection Method and Research Approach
  1. 16. Principal Presumptions and Acronyms